EXOME

all the information, none of the junk | biotech • healthcare • life sciences

See “New York’s Life Science Disruptors” on March 12: Here’s the Agenda

Xconomy New York — 

We’re coming down the home stretch towards our latest Big Apple biotech bash.

In just a few weeks, on March 12, Xconomy will bring the local biotech community together for “New York’s Life Science Disruptors” at the Alexandria Center for Life Science at East River Science Park. It’s a candid event; you’ll hear the behind-the-scenes stories of some of the key figures who are trying to mold New York biotech. The full agenda is here.

Acorda Therapeutics (NASDAQ: ACOR) CEO Ron Cohen has come aboard to moderate one of our chats. Here are the others you’ll see:

George Yancopoulos: Scientific founder and chief scientific officer of Tarrytown, NY-based Regeneron Pharmaceuticals (NASDAQ: REGN). Yancopoulos is a principal inventor of Regeneron’s three FDA-approved drugs, and helped launch the Regeneron Genetics Center, which aims to sequence DNA from some 100,000 volunteers.

Robert Darnell: President and CEO of the New York Genome Center, a collaborative effort between 12 of the region’s big research institutions.

Thong Le: CEO of Accelerator Corp., which invests in early-stage biotechs and just opened a New York branch last year.

Misti Ushio: Managing director of New York venture firm Harris & Harris Group, and boardmember of Accelerator-NYC.

Sam Waksal: Chairman and Founder of New York-based Kadmon, and the former president and CEO of ImClone Systems. He’ll share some opening remarks.

Meg Tirrell: Biotechnology and pharmaceuticals reporter on CNBC, who, like Cohen, will join us as a chat moderator.

The festivities kick off at 5 p.m. with a networking reception before we get the show going at 6. You can grab your tickets here. See you all at the Alexandria Center in a few weeks.